Cryptococcal meningitis: its apparent increased incidence in the Far East.
D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D044466:Asian People; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002648:Child; D010856:Columbidae; D003453:Cryptococcosis / Q000188:drug therapy / Q000453:epidemiology*; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D003596:Cytosine / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005947:Glucose / Q000134:cerebrospinal fluid; D006801:Humans; D006973:Hypertension / Q000150:complications; D008171:Lung Diseases / Q000150:complications; D008297:Male; D008581:Meningitis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000401:mortality; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications; D010437:Peptic Ulcer / Q000150:complications; D011379:Prognosis; D012559:Schizophrenia / Q000150:complications; D012846:Singapore; D014390:Tuberculosis, Meningeal / Q000453:epidemiology
D002556:Cerebrospinal Fluid Proteins; D000666:Amphotericin B; D003596:Cytosine; D005947:Glucose